SCYNEXIS to Present Commercial Launch Update for BREXAFEMME® (ibrexafungerp tablets)

NEXT STORY
Medicenna Announces Submission of Clinical Trial Application in Australia for a Phase 1/2 Study of MDNA11
PREV STORY
$74 Billion Pain Management Drugs Global Market to 2026 – by Drug Class, Indication, Distribution Channel and Region
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Motif Bio Invited to Present at Infectious Diseases Conference

NEW YORK, June 22, 2017 (GLOBE NEWSWIRE) -- Motif Bio plc (NASDAQ:MTFB)(AIM:MTFB.LN), a clinical ...

author_avatar
NASDAQ Market News

Cellectar Biosciences to Present at 29th Annual Roth Conference

MADISON, Wis., March 06, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), an oncology-focused, ...

author_avatar
NASDAQ Market News

Precision Therapeutics to Hold Business Update Conference Call on April 2, 2018

MINNEAPOLIS, March 26, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the ...

author_avatar
NASDAQ Market News